Cargando…

Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet’s syndrome: case series and literature review

OBJECTIVES: This study aimed to investigate the efficacy and safety of tocilizumab (TCZ) in severe and refractory parenchymal neuro-Behçet’s syndrome (p-NBS). METHODS: We retrospectively analyzed five patients with p-NBS treated with TCZ in our center between 2013 and 2020, and six cases from litera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jinjing, Yan, Dong, Wang, Zhimian, Yang, Yunjiao, Zhang, Shangzhu, Wu, Di, Peng, Lingyi, Liu, Zhichun, Zheng, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675870/ https://www.ncbi.nlm.nih.gov/pubmed/33240406 http://dx.doi.org/10.1177/1759720X20971908

Ejemplares similares

The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease
por: Yan, Dong, et al.
Publicado: (2019)

Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet’s Syndrome with refractory vascular or neurological involvement: a case series
por: Sun, Luxi, et al.
Publicado: (2022)

Severe panuveitis in neuro-Behçet’s disease in Malaysia: a case series
por: Othman, Khairuddin, et al.
Publicado: (2017)

Tocilizumab for refractory morphea in adults: A case series
por: Lonowski, Sarah, et al.
Publicado: (2022)

Unusual Late Onset of Parenchymal Neuro-Behçet Disease
por: Miller, Wai Wai, et al.
Publicado: (2016)

Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center
por: Sun, Luxi, et al.
Publicado: (2021)

Radiation therapy for pineal parenchymal tumor of intermediate differentiation: A case series and literature review
por: Liu, Cassie, et al.
Publicado: (2023)

Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
por: Karabulut, Yusuf
Publicado: (2022)

Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature
por: Doan, Serge, et al.
Publicado: (2016)

Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet’s Disease
por: Li, Lu, et al.
Publicado: (2021)

Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behçet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2022)

Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis
por: Ishido, Mizuho, et al.
Publicado: (2017)

Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study
por: Desbois, Anne Claire, et al.
Publicado: (2016)

Correction: Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behcet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2022)

Neuro-Behcet disease
por: Zhang, Lin, et al.
Publicado: (2021)

Pulmonary hypertensive vasculopathy in parenchymal lung diseases and/or hypoxia: Number 1 in the Series “Pathology for the clinician” Edited by Peter Dorfmüller and Alberto Cavazza
por: Ghigna, Maria Rosa, et al.
Publicado: (2017)

Two Cases of Probable Neuro-Behçet's Disease with Longitudinally Extensive Transverse Myelitis
por: Fujiwara, Shunya, et al.
Publicado: (2021)

Neuro-Behçet’s syndrome with a severe ocular lesion
por: Han, Dan, et al.
Publicado: (2019)

Series of rare lung diseases mimicking imaging patterns of common diffuse parenchymal lung diseases
por: Batra, Kiran, et al.
Publicado: (2018)

Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil
por: Hwang, Sungeun, et al.
Publicado: (2021)

Behçet oculaire
por: Alami, Ahmed, et al.
Publicado: (2017)

Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet’s uveitis
por: Shi, Jing, et al.
Publicado: (2019)

Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series
por: Basnet, Ajaya, et al.
Publicado: (2022)

Neuro-Behcet's syndrome: Case report and literature review()
por: Peine, Brian, et al.
Publicado: (2022)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series
por: Lester, Jacobo, et al.
Publicado: (2018)

Neuro-Behçets in a Child
por: Vesoulis, Zachary A., et al.
Publicado: (2014)

Chorea in Neuro-Behçet’s Disease
por: Hamid, Mohamed, et al.
Publicado: (2021)

Neuro-Behçet’s Disease With Coma
por: Hamid, Mohamed, et al.
Publicado: (2022)

Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series
por: Cui, Ran, et al.
Publicado: (2021)

Role of Tofisopam in Post COVID Neuro-psychiatric Sequelae: A Case Series
por: Pattnaik, Jigyansa ipsita, et al.
Publicado: (2021)

Radiological findings in Behçet disease
por: Mohamed, Chraa, et al.
Publicado: (2015)

Efficacy and safety of tocilizumab in Behçet’s syndrome with refractory arterial lesions: a single-centre observational cohort study in China
por: Zhong, Hua, et al.
Publicado: (2021)

Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
por: Dunn, Charles, et al.
Publicado: (2023)

Good response to rectal diazepam in refractory cases of cyclic vomiting: A case‐series and review of the literature
por: Togha, Mansoureh, et al.
Publicado: (2023)

Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
por: Mady, Ahmed, et al.
Publicado: (2020)

Extracorporeal membrane oxygenation support and total thyroidectomy in patients with refractory thyroid storm: case series and literature review
por: Alahmad, Murad, et al.
Publicado: (2022)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
por: Shahriari, Neda, et al.
Publicado: (2023)

Neuro-Behçet Disease, Neuro-Sweet Disease, and Spectrum Disorders
por: Hisanaga, Kinya
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s2shceudit0j2qtpsddeaiobhe